ProShare Advisors »

Aeglea Biotherapeutics shares owned by ProShare Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by ProShare Advisors from 13F filings

Historical chart of ProShare Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by ProShare Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $179k 11k 16.76
2025-06-30 $187k 13k 14.97
2025-03-31 $184k 11k 16.14
2024-12-31 $292k 13k 23.28